Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-29

Clinical Trial Update: Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of BRIMOCHOL PF and CARBACHOL PF for presbyopia in Chinese patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIMOCHOL PF (carbachol)
  • Carbachol PF (carbachol)

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Presbyopia | Phase 2 | Status: RECRUITING